The Pathogenesis of COVID-19 Myocardial Injury: An Immunohistochemical Study of Postmortem Biopsies

Front Immunol. 2021 Nov 5:12:748417. doi: 10.3389/fimmu.2021.748417. eCollection 2021.

Abstract

Rationale: Myocardial injury associates significantly and independently with mortality in COVID-19 patients. However, the pathogenesis of myocardial injury in COVID-19 remains unclear, and cardiac involvement by SARS-CoV-2 presents a major challenge worldwide.

Objective: This histological and immunohistochemical study sought to clarify the pathogenesis and propose a mechanism with pathways involved in COVID-19 myocardial injury.

Methods and results: Postmortem minimally invasive autopsies were performed in six patients who died from COVID-19, and the myocardium samples were compared to a control group (n=11). Histological analysis was performed using hematoxylin-eosin and toluidine blue staining. Immunohistochemical (IHC) staining was performed using monoclonal antibodies against targets: caspase-1, caspase-9, gasdermin-d, ICAM-1, IL-1β, IL-4, IL-6, CD163, TNF-α, TGF-β, MMP-9, type 1 and type 3 collagen. The samples were also assessed for apoptotic cells by TUNEL. Histological analysis showed severe pericardiocyte interstitial edema and higher mast cells counts per high-power field in all COVID-19 myocardium samples. The IHC analysis showed increased expression of caspase-1, ICAM-1, IL-1β, IL-6, MMP-9, TNF-α, and other markers in the hearts of COVID-19 patients. Expression of caspase-9 did not differ from the controls, while gasdermin-d expression was less. The TUNEL assay was positive in all the COVID-19 samples supporting endothelial apoptosis.

Conclusions: The pathogenesis of COVID-19 myocardial injury does not seem to relate to primary myocardiocyte involvement but to local inflammation with associated interstitial edema. We found heightened TGF-β and interstitial collagen expression in COVID-affected hearts, a potential harbinger of chronic myocardial fibrosis. These results suggest a need for continued clinical surveillance of patients for myocardial dysfunction and arrythmias after recovery from the acute phase of COVID-19.

Keywords: COVID-19; SARS-CoV-2; endothelium; fibrosis; heart; immunohistochemistry; myocardial injury; pathology.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Apoptosis
  • Biopsy
  • COVID-19 / metabolism*
  • COVID-19 / pathology
  • Caspase 1 / metabolism
  • Collagen / metabolism
  • Cytokines / metabolism
  • Female
  • Heart Injuries / metabolism*
  • Heart Injuries / pathology
  • Humans
  • Immunohistochemistry
  • Intercellular Adhesion Molecule-1 / metabolism
  • Male
  • Matrix Metalloproteinase 9 / metabolism
  • Myocardium / metabolism
  • Myocardium / pathology
  • SARS-CoV-2*

Substances

  • Cytokines
  • ICAM1 protein, human
  • Intercellular Adhesion Molecule-1
  • Collagen
  • Caspase 1
  • MMP9 protein, human
  • Matrix Metalloproteinase 9